BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 24464787)

  • 1. The oncoprotein HBXIP enhances angiogenesis and growth of breast cancer through modulating FGF8 and VEGF.
    Liu F; You X; Wang Y; Liu Q; Liu Y; Zhang S; Chen L; Zhang X; Ye L
    Carcinogenesis; 2014 May; 35(5):1144-53. PubMed ID: 24464787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells.
    Liu S; Li L; Zhang Y; Zhang Y; Zhao Y; You X; Lin Z; Zhang X; Ye L
    J Biol Chem; 2012 Aug; 287(36):30228-39. PubMed ID: 22740693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oncoprotein HBXIP suppresses gluconeogenesis through modulating PCK1 to enhance the growth of hepatoma cells.
    Shi H; Fang R; Li Y; Li L; Zhang W; Wang H; Chen F; Zhang S; Zhang X; Ye L
    Cancer Lett; 2016 Nov; 382(2):147-156. PubMed ID: 27609066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oncoprotein HBXIP modulates the feedback loop of MDM2/p53 to enhance the growth of breast cancer.
    Li H; Liu Q; Wang Z; Fang R; Shen Y; Cai X; Gao Y; Li Y; Zhang X; Ye L
    J Biol Chem; 2015 Sep; 290(37):22649-61. PubMed ID: 26229107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
    Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
    Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oncoprotein HBXIP upregulates Lin28B via activating TF II D to promote proliferation of breast cancer cells.
    Liu Q; Bai X; Li H; Zhang Y; Zhao Y; Zhang X; Ye L
    Int J Cancer; 2013 Sep; 133(6):1310-22. PubMed ID: 23494474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncoprotein HBXIP upregulates PDGFB via activating transcription factor Sp1 to promote the proliferation of breast cancer cells.
    Zhang Y; Zhao Y; Li L; Shen Y; Cai X; Zhang X; Ye L
    Biochem Biophys Res Commun; 2013 May; 434(2):305-10. PubMed ID: 23537647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer.
    Liu F; Zhang W; You X; Liu Y; Li Y; Wang Z; Wang Y; Zhang X; Ye L
    Oncotarget; 2015 Sep; 6(29):27199-213. PubMed ID: 26309161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oncoprotein HBXIP up-regulates YAP through activation of transcription factor c-Myb to promote growth of liver cancer.
    Wang Y; Fang R; Cui M; Zhang W; Bai X; Wang H; Liu B; Zhang X; Ye L
    Cancer Lett; 2017 Jan; 385():234-242. PubMed ID: 27765671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oncoprotein HBXIP enhances migration of breast cancer cells through increasing filopodia formation involving MEKK2/ERK1/2/Capn4 signaling.
    Li Y; Zhang Z; Zhou X; Li L; Liu Q; Wang Z; Bai X; Zhao Y; Shi H; Zhang X; Ye L
    Cancer Lett; 2014 Dec; 355(2):288-96. PubMed ID: 25304384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via Sp1 to promote proliferation of breast cancer cells.
    Yue L; Li L; Liu F; Hu N; Zhang W; Bai X; Li Y; Zhang Y; Fu L; Zhang X; Ye L
    Carcinogenesis; 2013 Apr; 34(4):927-35. PubMed ID: 23291272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
    Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
    Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathways.
    Li H; Wang Z; Jiang M; Fang RP; Shi H; Shen Y; Cai XL; Liu Q; Ye K; Fan SJ; Zhang WY; Ye LH
    Acta Pharmacol Sin; 2018 Nov; 39(11):1787-1796. PubMed ID: 30181579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBXIP accelerates glycolysis and promotes cancer angiogenesis via AKT/mTOR pathway in bladder cancer.
    Liu X; Li H; Che N; Zheng Y; Fan W; Li M; Li X; Xuan Y
    Exp Mol Pathol; 2021 Aug; 121():104665. PubMed ID: 34216584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncoprotein HBXIP Modulates Abnormal Lipid Metabolism and Growth of Breast Cancer Cells by Activating the LXRs/SREBP-1c/FAS Signaling Cascade.
    Zhao Y; Li H; Zhang Y; Li L; Fang R; Li Y; Liu Q; Zhang W; Qiu L; Liu F; Zhang X; Ye L
    Cancer Res; 2016 Aug; 76(16):4696-707. PubMed ID: 26980761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncoprotein HBXIP up-regulates FGF4 through activating transcriptional factor Sp1 to promote the migration of breast cancer cells.
    Shi H; Li Y; Feng G; Li L; Fang R; Wang Z; Qu J; Ding P; Zhang X; Ye L
    Biochem Biophys Res Commun; 2016 Feb; 471(1):89-94. PubMed ID: 26828265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin alpha x stimulates cancer angiogenesis through PI3K/Akt signaling-mediated VEGFR2/VEGF-A overexpression in blood vessel endothelial cells.
    Wang J; Yang L; Liang F; Chen Y; Yang G
    J Cell Biochem; 2019 Feb; 120(2):1807-1818. PubMed ID: 30873824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
    Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
    Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncoprotein HBXIP induces PKM2 via transcription factor E2F1 to promote cell proliferation in ER-positive breast cancer.
    Liu BW; Wang TJ; Li LL; Zhang L; Liu YX; Feng JY; Wu Y; Xu FF; Zhang QS; Bao MZ; Zhang WY; Ye LH
    Acta Pharmacol Sin; 2019 Apr; 40(4):530-538. PubMed ID: 29925919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein can upregulate VEGF expression to promote ADSC-induced angiogenesis by activating HIF-1α via CD64/PI3k/Akt and MAPK/ERK signaling pathways.
    Chen J; Gu Z; Wu M; Yang Y; Zhang J; Ou J; Zuo Z; Wang J; Chen Y
    Stem Cell Res Ther; 2016 Aug; 7(1):114. PubMed ID: 27526687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.